Utah Medical Products (Utah Medical Products) Debt-to-Equity : 0.00 (As of Dec. 2023)

View and export this data going back to 1999. Start your Free Trial

What is Utah Medical Products Debt-to-Equity?

Utah Medical Products's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.00 Mil. Utah Medical Products's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.30 Mil. Utah Medical Products's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $128.31 Mil. Utah Medical Products's debt to equity for the quarter that ended in Dec. 2023 was 0.00.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Utah Medical Products's Debt-to-Equity or its related term are showing as below:

During the past 13 years, the highest Debt-to-Equity Ratio of Utah Medical Products was 0.08. The lowest was 0.00. And the median was 0.00.

UTMD's Debt-to-Equity is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 0.21
* Ranked among companies with meaningful Debt-to-Equity only.

Utah Medical Products Debt-to-Equity Historical Data

The historical data trend for Utah Medical Products's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Utah Medical Products Debt-to-Equity Chart

Utah Medical Products Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

Utah Medical Products Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Utah Medical Products's Debt-to-Equity

For the Medical Instruments & Supplies subindustry, Utah Medical Products's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Utah Medical Products's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Utah Medical Products's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Utah Medical Products's Debt-to-Equity falls into.

Utah Medical Products Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Utah Medical Products's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0.295)	/	128.313
	=	0.00

Utah Medical Products's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0.295)	/	128.313
	=	0.00

Utah Medical Products (NAS:UTMD) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Utah Medical Products Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Utah Medical Products's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Utah Medical Products (Utah Medical Products) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Utah Medical Products Inc (NAS:UTMD) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

UTM:Germany

Address

7043 South 300 West, Midvale, UT, USA, 84047

Website

http://www.utahmed.com

Utah Medical Products Inc is involved in the business of developing, manufacturing, and distributing medical devices that are mainly proprietary, disposable and for hospital use. The firm produces its products for Blood pressure monitoring, Blood collection, Electrosurgery, Gynecology, Neonatal critical care, perinatology, and Urology. The company's product portfolio includes Electrosurgical pens, Tenacula, Endoscopic bulb irrigators, Blood bag spikes. Its products are used mainly in critical care areas, labor and delivery departments of hospitals as well as outpatient clinics and physicians offices.

Executives

Paul O Richins	director, officer: VP, Treasurer, Asst. Secretary	7043 SOUTH 300 WEST, MIDVALE UT 84047
Barbara A Payne	director
Ernst G Hoyer	director
Kevin L Cornwell	director, officer: Chairman, CEO, Secretary
Brian Koopman	officer: Principal Financial Officer	108 E 1700 S, BOUNTIFUL UT 84010
James H Beeson	director	7043 SOUTH 300 WEST, MIDVALE UT 84047
Greg A Leclaire	officer: Chief Financial Officer	5225 WILEY POST WAY, SUITE 500, SALT LAKE CITY UT 84116
Stephen W Bennett	director